Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function

Hellenic J Cardiol. 2019 Mar-Apr;60(2):143-145. doi: 10.1016/j.hjc.2018.07.001. Epub 2018 Jul 6.

¹ Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra University Hospital, 80 V. Sofias Str, 11528 Athens, Greece. Electronic address: [email protected].
² 2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
³ Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra University Hospital, 80 V. Sofias Str, 11528 Athens, Greece.
⁴ 1st Cardiology Clinic, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

No abstract available

Keywords: Chronic hepatitis C; Functional cardiovascular markers; Pegylated-interferon; Ribavirin; Structural cardiovascular markers.

Publication types